Showing results (1621-1630 of 1,950) with videos related to
Sort By:
Pageof 195
British Journal of Cancer|July 3, 2008
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell linesG D Stewart, R J E Skipworth, C J Pennington, et al.British Journal of Cancer|March 3, 2011
Strengthening clinical cancer research in the United KingdomM Stead, D Cameron, N Lester, et al.Journal of Clinical Microbiology|September 29, 2017
Multilaboratory Evaluation of a Novel Lateral Flow Immunochromatographic Assay for Confirming Isolation of Mycobacterium bovis from Veterinary Diagnostic SpecimensLinda D Stewart, Lyanne McCallan, James McNair, et al.Bone Marrow Transplantation|May 1, 1997
Partially mismatched blood cell transplants for high-risk hematologic malignancyJ A Russell, S Desai, B Herbut, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.Cancers|May 16, 2023
Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung CancerLiam J Brockley, Vanessa G P Souza, Aisling Forder, et al.Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategiesKieu Trinh Do, Simone Wahl, Johannes Raffler, et al.Age and Ageing|July 16, 2024
The electronic frailty index and outcomes in patients with myocardial infarctionMatthew T H Lowry, Dorien M Kimenai, Dimitrios Doudesis, et al.Molecular Cancer Therapeutics|December 21, 2002
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylaseKeith B Glaser, Junling Li, Mary E Aakre, et al.Bone Marrow Transplantation|May 1, 1996
Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantationJ A Russell, C Brown, T Bowen, et al.Pageof 195